e-learning
resources
London 2016
Wednesday, 07.09.2016
Airway pharmacology: drug targets and mode of action
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Budesonide and fluticasone propionate exertdifferential effects on human bronchial epithelial cells exposed to streptococcus pneumoniae and viral mimetic
Irene Heijink (Groningen, Netherlands), H. Irene Heijink, Marnix Jonker, Dirkje S. Postma, Maarten van den Berge
Source:
International Congress 2016 – Airway pharmacology: drug targets and mode of action
Session:
Airway pharmacology: drug targets and mode of action
Session type:
Poster Discussion
Number:
5061
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Irene Heijink (Groningen, Netherlands), H. Irene Heijink, Marnix Jonker, Dirkje S. Postma, Maarten van den Berge. Budesonide and fluticasone propionate exertdifferential effects on human bronchial epithelial cells exposed to streptococcus pneumoniae and viral mimetic. Eur Respir J 2016; 48: Suppl. 60, 5061
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Differential effects of budesonide and fluticasone propionate on bacterial recognition receptors in COPD macrophages
Source: International Congress 2016 – Airway response to infection
Year: 2016
Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Anti-inflammatory effect of the combination of a long acting β2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following
staphylococcus aureus
virulence factors challenge
Source: Eur Respir J 2006; 28: Suppl. 50, 104s
Year: 2006
Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Anti-inflammatory effect of the combination of a long acting beta2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following
Staphylococcus aureus
infection
Source: Eur Respir J 2005; 26: Suppl. 49, 98s
Year: 2005
Fluticasone propionate reduces bacterial airway epithelial invasion
Source: Eur Respir J 2008; 32: 1283-1288
Year: 2008
Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Comparison of budesonide and fluticasone propionate on COPD macrophage phagocytosis and killing of bacteria
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Effect of clarithromycin on rhinovirus-16 infection in A549 cells
Source: Eur Respir J 2006; 27: 12-19
Year: 2006
Effect of roflumilast N-oxide on non-typable
haemophilus influenzae
(NTHi) interaction with human airway epithelial A549 cells
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Effect of corticosteroids on epithelial cell response to non-typeable haemophilus influenzae
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Initial interaction of fluticasone propionate with ciliated respiratory epithelium
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
Comparison of fluticasone propionate and budesonide on phagocytosis of common respiratory pathogens in COPD patients
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
Rhinovirus infection of human ciliated respiratory epithelial cultures
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
T regulatory cells: Immunomodulation by budesonide and formoterol on COPD patients
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 and killing of non-typeable haemophilus influenzae (NTHi) is reduced after 14 days exposure to TNF-α and IL-1β in primary bronchial epithelial cells (PBEC)
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept